On Wednesday, Texas and Florida filed a sweeping lawsuit against the U.S. Food and Drug Administration, seeking to overturn more than two decades of policy that have shaped how Americans access the most commonly used abortion drug in the country. The states are challenging the FDA’s original 2000 approval of mifepristone, its recent authorization of a new generic version, and a series of later policies that expanded access to the medication, including via mail delivery.

These actions, according to the lawsuit, were “ arbitrary, capricious, an abuse of discretion, not in accordance with law, and therefore invalid under the Administrative Procedure Act.”

Related

The complaint claims that the agency failed to adequately evaluate the drug’s safety and improperly relaxed safeguards under pol

See Full Page